ABSTRACT. Thromboxane-associated pulmonary hypertension occurs in animals during intravenous infusion of group B streptococcus (GBS), a gram-positive neonatal pathogen. We postulated that other gram-positive neonatal pathogens, such as Streptococcus fecalis (ENT) and Staphylococcus epidermidis (S. epi) would also induce increased thromboxane synthesis and pulmonary hypertension when infused into piglets. We observed similar hemodynamic and gas exchange abnormalities during stepwise increases in the dose of GBS, Ent, and S. epi (n = 3,4, and 4 piglets receiving each bacteria, respectively). Pulmonary vascular resistance increased significantly in the absence of acidosis or reduced arterial or mixed venous pOz at a dose of 2.5 x 10' cfu/kg/h for Ent and S. epi. In 14 additional piglets, pulmonary vascular resistance increased markedly after 60 min of intravenous infusion of 4 f 1 x 10' cfu/kg/h for each organism (p < 0.05, GBS: 11.7 f 1.8 to 75.6 f 18.4 mm Hg/liter/min, Ent: 12.7 f 1.7 to 64.9 f 10.6 mm Hg/ liter/min, S. epi: 10.5 f 0.8 to 56.9 f 6.0 mm Hg/liter/ min), and blood thromboxane B2 levels increased (p < 0.05, GBS: 30 f 10 to 1830 f 330 pglml, Ent: 20 f 7 to 1110 f 300 pglml, S. epi: 31 f 9 to 1260 f 350 pg/ml).This dose of each bacteria caused a similar degree of mild arterial hypoxemia (57-66 mm Hg). The thromboxane synthetase inhibitor, dazmegrel, completely reversed pulmonary hypertension, reduced TxB2 levels to near baseline values, and partially reversed arterial hypoxemia despite ongoing bacterial infusion. We conclude that thromboxaneassociated pulmonary hypertension occurs in piglets during infusion of different gram-positive neonatal pathogens. (Pediatr Res 23: 553-556, 1988) Abbreviations cfu, colony forming units C.O., cardiac output DAZ, dazmegrel Ent, Streptococcus fecalis (enterococcus) P,,, proximal airway pressure P,,, systemic arterial pressure GBS, a common gram-positive neonatal pathogen, causes acute pulmonary hypertension, arterial hypoxemia, and decreased cardiac output when infused into both adult and neonatal animals (1-3). In animals with GBS bacteremia and in some human newborns with GBS sepsis, pulmonary hypertension is associated with elevated blood levels of TxB2, the stable metabolite of the potent vasoconstrictor thromboxane A2 (2, 4, 5).
Inhibitors of thromboxane synthesis, such as DAZ (UK 38,485),can prevent or reverse pulmonary hypertension in animals with GBS bacteremia (4, 6).The fact that both gram-positive bacteria, e.g. GBS, and some gram-negative bacteria, e.g. E scherichia coli and Aeromonas hydrophilia (7,8), can cause thromboxane-associated pulmonary hypertension suggests a lack of bacterial specificity for this pulmonary vascular response. Gram-positive neonatal pathogens other than GBS, such as Ent and S. epi, can contribute to respiratory failure and morbidity in human newborns (9, 10).However, there are no reports on the pulmonary hemodynamic effects of these other gram-positive bacteria.We postulated that the intravenous infusion of gram-positive neona...